アリゾナ州における膠芽腫の臨床試験
アリゾナ州内の拠点で、膠芽腫に関する13件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
- Mayo Clinic Hospital in Arizona, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05432804Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
- Mayo Clinic Arizona, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05902169Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- HonorHealth Scottsdale Osborn Medical Center, Scottsdale
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07195591Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
- Banner MD Anderson Cancer Center, Gilbert
- Arizona Cancer Center at UMC North/University Medical Center, Tucson
被験者募集中第1/2相
18歳〜99歳 · 全性別 · 2026/09/22更新 · NCT06814496SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Mayo Clinic - Arizona, Phoenix
- St. Joseph's Hospital and Medical Center, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT05303519BGB-58067 in Newly Diagnosed Glioblastoma Patients With MTAP-Deleted Tumors
- St. Joseph's Hospital and Medical Center, Phoenix
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/08/21更新 · NCT07485049Continuous Glucose Monitoring for the Management of Hyperglycemia in Patients With Glioblastoma
- Mayo Clinic in Arizona, Phoenix
被験者募集中
18歳以上 · 全性別 · 2026/08/17更新 · NCT07091864Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
- Honor Health, Scottsdale
被験者募集中
18歳〜85歳 · 全性別 · 2026/07/21更新 · NCT06910306A Phase 1/2 Study of the Safety and Tolerability of MT-125 in GBM Patients
- Mayo Clinic Hospital, Phoenix
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/14更新 · NCT07185880Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Scottsdale, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Patients With Recurrent Grade 4 Glioma and Patients With Brain Metastases
- St. Joseph's Hospital and Medical Center, Phoenix
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/03/06更新 · NCT07268053A Phase 0/1 Study of BDTX-1535 in Recurrent High-Grade Glioma (rHGG) and Newly Diagnosed Glioblastoma (nGBM) Participants With EGFR Alterations or Fusions
- Chandler Regional Medical Center, Chandler
- St. Joseph's Hospital and Medical Center, Phoenix
被験者募集中早期第1相
18歳以上 · 全性別 · 2025/11/20更新 · NCT06072586SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。